Quantum Healthcare’s FY2025 revenue rose to SGD 13.1 million (+3.0%), while Q4 revenue was SGD 3.5 million (+0.8%). FY2025 net loss was SGD 2.9 million (+13.8%), and Q4 net loss was SGD 2.3 million (+80.9%), with FY2025 loss attributable to shareholders of SGD 2.8 million. The company reported FY2025 operating cash inflow of SGD 2.0 million and ended FY2025 with cash and cash equivalents of SGD 2.7 million, up from SGD 0.4 million. Quantum Healthcare said the FY2025 revenue increase was mainly due to the commencement of operations at its new clinic, TDH Sengkang, in July 2024. It also cited higher FY2025 other expenses driven mainly by a goodwill impairment of SGD 2.2 million, while noting ongoing cost pressures and manpower constraints in its industry, and that it continues to explore strategic options, fundraising opportunities and growth in its dental business. The company also disclosed that it had used about SGD 0.6 million of gross proceeds from its September 2025 placement (SGD 3.0 million) for general working capital, with SGD 2.4 million remaining as at the announcement date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Healthcare Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: YDXFGV4Y1K2RV8ML) on February 28, 2026, and is solely responsible for the information contained therein.